RACE ONCOLOGY LTD - Charts / Financials

Market Cap $227.0M Add to my watchlist

Healthcare Biotechnology

Race Oncology Limited is an Australia-based precision oncology company with a Phase... Race Oncology Limited is an Australia-based precision oncology company with a Phase II/III cancer drug called Zantrene. Zantrene is a potent small molecule inhibitor of the Fatso/Fat mass and obesity associated (FTO) protein. The Company is exploring the use of Zantrene as a new therapy for melanoma and clear cell renal cell carcinoma (kidney cancer), which are both frequent FTO-driven cancers. Zantrene (bisantrene dihydrochloride) is a small molecule anti-cancer drug which has clinical and preclinical efficacy as both a low dose, highly targeted precision oncology agent and a cardio-protective chemotherapeutic. The Company also has clinical data for the use of Zantrene as a chemotherapeutic agent with reduced cardiotoxicity in acute myeloid leukemia (AML), breast and ovarian cancers and is investigating its use in these areas.More

BlinkLab Limited (ASX: BB1) is a trailblazer in digital healthcare, leveraging AI and machine learning in mobile applications to revolutioniSe neurodevelopmental condition diagnosis like ASD and ADHD. Born from extensive research at Princeton University,...

REFRESH

Last update - 15.59pm 19/04/2024 (20 minute delay)

Day
Open	$1.45		Day High	$1.45		Day Low	$1.37
Daily Volume	98696

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
1	$1.37	165		1	$1.40	7611

Directors & Senior Management

Mr. Peter Molloy	Chief Executive Officer
Dr. Daniel Tillett	Chief Executive Officer
Mr. Brendan Brown	Chief Financial Officer
Prof. Tim Hammond	Interim Chief Scientific Officer
Dr. Peter Smith	Executive Director
Prof. Borje S. Andersson	Chair – Clinical Advisory Board
Dr. Michelle Rashford	Chief Medical Officer
Mr. Peter Gordon Webse	Company Secretary
Ms. Mary Harney	Independent Non-Executive Chairman of the Board
Dr. John Cullity	Non-Executive Director
Mr. Phillip Lynch	Non-Executive Director

Data source: Refinitiv

(20min delay)
Last $1.37		Change -0.020(1.44%)		Mkt cap ! $227.0M

Open	High	Low	Value	Volume
$1.45	$1.45	$1.37	$137.3K	98.69K

Buyers (Bids)

No.	Vol.	Price($)
1	165	$1.37

Sellers (Offers)

Price($)	Vol.	No.
$1.40	7611	1

View Market Depth

No.	Vol.	Price($)
2	19206	1.365
1	40000	1.360
2	4400	1.350
1	94	1.330
1	747	1.325

Price($)	Vol.	No.
1.410	3370	1
1.500	6756	2
1.510	312	1
1.520	1757	1
1.590	2350	1

Last trade - 16.10pm 19/04/2024 (20 minute delay)


Last $1.38		Change -0.020 ( 4.43 %)
Open	High	Low	Volume
$1.43	$1.44	$1.38	5981
Last updated 15.59pm 19/04/2024 ?

RAC (ASX) Chart

RACE ONCOLOGY LTD - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories